You're reading the free version. Trader adds the live tape and alerts.
Start tracking
ORKA Sale Disclosure
Sandler Laura Lee · SEC Form 4 · Filed Jul 1, 2026
Sale
Calculated transaction value
$214.41K
Sandler Laura Lee Chief Operating Officer
ORKA
Oruka Therapeutics
ORKA
Transaction date
Jul 1, 2026
Public filing date
Jul 1, 2026
Filing lag
Filed same day
ORKA daily price context
Close on/before transaction
$93.29
Jul 1, 2026
First close after public filing
$85.21
Jul 2, 2026
30-day return after filing
+13.26%
Through Jul 31, 2026
Source details
- Reported owner
- Not disclosed
- Source asset code
- Security
- Security
- Common Stock
- Quantity / price
- 2,263 shares @ $94.75
- SEC ownership
- Direct
- Transaction code
- S
- Form
- 4
- Filing identifier
- 0000907654-26-000069
Filing cohort
Transactions in this filing
Showing 5 of 5
Trades
5
Issuers
1
Estimated value
$511.08K
Buys / sales
0 / 3
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Oruka Therapeutics, Inc. ORKA | Sale | Jul 1, 2026 | $209.93K |
| Oruka Therapeutics, Inc. ORKA Current | Sale | Jul 1, 2026 | $214.41K |
| Oruka Therapeutics, Inc. ORKA | Sale | Jul 1, 2026 | $47.74K |
| Oruka Therapeutics, Inc. ORKA | Exercise | Jul 1, 2026 | $0 |
| Oruka Therapeutics, Inc. ORKA | Exercise | Jul 1, 2026 | $39K |